Respiration
Continuous Measurement of Respiratory Resistance in Asthmatic ChildrenWanner A. · Zarzecki S. · Marks M.B.The Jane and Edward Shapiro Pulmonary Suite, Division of Pulmonary Disease, Department of Internal Medicine, Mount Sinai Medical Center, Miami Beach, Fla
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Received: June 02, 1975
Accepted: August 20, 1975
Published online: January 14, 2009
Issue release date: 1977
Number of Print Pages: 8
Number of Figures: 0
Number of Tables: 0
ISSN: 0025-7931 (Print)
eISSN: 1423-0356 (Online)
For additional information: https://www.karger.com/RES
Abstract
In 13 children (7–13 years old) with bronchial asthma in remission, respiratory system resistance was continuously measured by the forced oscillation method at 10 Hz, using on-line digital computer analysis. Corrections were made for mouth impedance which was determined from a prior Valsalva maneuver. Functional residual capacity was also periodically determined by the body plethysmographic technique in order to allow calculation of specific respiratory system conductance (SGrs). The total observation period of 45 min consisted of quiet breathing interrupted by vital capacity maneuvers. In a single-blind design, eight children were given 0.15 mg isoproterenol sulfate from a proprietary spray delivered in the beginning of an inspiratory vital capacity maneuver while five received a placebo (freon propellent alone). A significant increase in SGrs (+53%) was observed 75 sec after isoproterenol sulfate administration. SGrs peaked after 2 min (+61%) and remained elevated significantly for 10 min. No significant changes occurred in the placebo group. The immediate decrease in SGrs which was observed following control vital capacity maneuvers, was prevented by isoproterenol sulfate but not by the freon propellent. Our findings suggest that although peak bronchodilation does not occur before 2 min following isoproterenol sulfate inhalation, an effect, namely prevention of bronchoconstriction induced by a deep breath, is already detectable within seconds.
© 1977 S. Karger AG, Basel
Related Articles:
Article / Publication Details
Received: June 02, 1975
Accepted: August 20, 1975
Published online: January 14, 2009
Issue release date: 1977
Number of Print Pages: 8
Number of Figures: 0
Number of Tables: 0
ISSN: 0025-7931 (Print)
eISSN: 1423-0356 (Online)
For additional information: https://www.karger.com/RES
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Get Permission